Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C.

Hum Mutat. 2010 Jul;31(7):763-80. doi: 10.1002/humu.21277. Review.

2.

Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.

Yonova-Doing E, Atadzhanov M, Quadri M, Kelly P, Shawa N, Musonda ST, Simons EJ, Breedveld GJ, Oostra BA, Bonifati V.

Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.

PMID:
22445250
3.

Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.

Nuytemans K, Meeus B, Crosiers D, Brouwers N, Goossens D, Engelborghs S, Pals P, Pickut B, Van den Broeck M, Corsmit E, Cras P, De Deyn PP, Del-Favero J, Van Broeckhoven C, Theuns J.

Hum Mutat. 2009 Jul;30(7):1054-61. doi: 10.1002/humu.21007.

PMID:
19405094
4.

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

Choi JM, Woo MS, Ma HI, Kang SY, Sung YH, Yong SW, Chung SJ, Kim JS, Shin HW, Lyoo CH, Lee PH, Baik JS, Kim SJ, Park MY, Sohn YH, Kim JH, Kim JW, Lee MS, Lee MC, Kim DH, Kim YJ.

Neurogenetics. 2008 Oct;9(4):263-9. doi: 10.1007/s10048-008-0138-0. Epub 2008 Aug 15.

PMID:
18704525
5.

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR.

Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6. Review.

PMID:
22956510
6.

Pathogenic mutations in Parkinson disease.

Tan EK, Skipper LM.

Hum Mutat. 2007 Jul;28(7):641-53. Review.

PMID:
17385668
7.

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C.

Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.

8.

Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.

Macedo MG, Verbaan D, Fang Y, van Rooden SM, Visser M, Anar B, Uras A, Groen JL, Rizzu P, van Hilten JJ, Heutink P.

Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.

PMID:
18973254
9.

Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.

Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S, Garavaglia B, Uncini A, Palka G, Stuppia L, Dallapiccola B.

Mov Disord. 2007 Nov 15;22(15):2274-8.

PMID:
17914726
10.

Impact of recent genetic findings in Parkinson's disease.

Klein C, Lohmann-Hedrich K.

Curr Opin Neurol. 2007 Aug;20(4):453-64. Review.

PMID:
17620882
11.

Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.

Koziorowski D, Hoffman-Zacharska D, Sławek J, Jamrozik Z, Janik P, Potulska-Chromik A, Roszmann A, Tataj R, Bal J, Friedman A.

Neurol Neurochir Pol. 2013 Jul-Aug;47(4):319-24.

PMID:
23986421
12.

Clinical genetics of Parkinson's disease and related disorders.

Wider C, Wszolek ZK.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Review.

PMID:
18267241
13.

Clinical implications of gene discovery in Parkinson's disease and parkinsonism.

Wider C, Foroud T, Wszolek ZK.

Mov Disord. 2010;25 Suppl 1:S15-20. doi: 10.1002/mds.22723.

PMID:
20187245
14.

Genetics of Parkinson's disease and parkinsonism.

Douglas MR, Lewthwaite AJ, Nicholl DJ.

Expert Rev Neurother. 2007 Jun;7(6):657-66. Review.

PMID:
17563249
15.

Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.

Moura KC, Junior MC, de Rosso AL, Nicaretta DH, Pereira JS, José Silva D, Santos-Rebouças CB, Pimentel MM.

Dis Markers. 2012;32(3):173-8. doi: 10.3233/DMA-2011-0873.

16.

[Function study advances of Parkinson disease related genes].

Wang XM, Wang DQ, Wang XY.

Yi Chuan. 2010 Aug;32(8):779-84. Review. Chinese.

PMID:
20709674
17.

[Genetics and present therapy options in Parkinson's disease: a review].

Bereznai B, Molnar MJ.

Ideggyogy Sz. 2009 May 30;62(5-6):155-63. Review. Hungarian.

PMID:
19579663
18.

Genetics and epigenetics of Parkinson's disease.

Coppedè F.

ScientificWorldJournal. 2012;2012:489830. doi: 10.1100/2012/489830. Epub 2012 May 1.

19.

Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.

Mellick GD, Siebert GA, Funayama M, Buchanan DD, Li Y, Imamichi Y, Yoshino H, Silburn PA, Hattori N.

Parkinsonism Relat Disord. 2009 Feb;15(2):105-9. doi: 10.1016/j.parkreldis.2007.11.016. Epub 2008 May 19.

PMID:
18486522
20.

[Familial Parkinsonism].

Hasegawa K.

No To Shinkei. 2006 Aug;58(8):671-80. Review. Japanese. No abstract available.

PMID:
16986673

Supplemental Content

Support Center